Literature DB >> 2802900

Risk factors for hospital-acquired candidemia. A matched case-control study.

S B Wey1, M Mori, M A Pfaller, R F Woolson, R P Wenzel.   

Abstract

Nosocomial candidemia has become an important infection not only because of an apparently increasing incidence but also because of its high fatality rate. We studied 28 risk factors through a matched case-control study that included 88 pairs of patients hospitalized between July 1983 and December 1986. The strongest single risk factor found in the univariate analysis was the number of prior antibiotics administered: the exposure odds ratio (OR) was 12.50 when patients who received three to five antibiotics were compared with those who received none to two antibiotics. A multiple logistic regression analysis using a conditional likelihood method was performed to evaluate several risk factors simultaneously. The final model selected by a stepwise procedure included the following variables: number of antibiotics received prior to infection (OR, 1.73 per unit increase), isolation of Candida species from sites other than blood (OR, 10.37), prior hemodialysis (OR, 18.13), and prior use of a Hickman catheter (OR, 7.23). It remains to be shown in controlled clinical trials whether limiting the number of antibiotics or instituting prophylaxis and/or early treatment for high-risk patients will reduce the incidence of nosocomial candidemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2802900

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  119 in total

1.  Experience with invasive Candida infections.

Authors:  H Girishkumar; A M Yousuf; J Chivate; E Geisler
Journal:  Postgrad Med J       Date:  1999-03       Impact factor: 2.401

Review 2.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

3.  Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization.

Authors:  N Febré; V Silva; E A Medeiros; S B Wey; A L Colombo; O Fischman
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Perioperative variation in phagocytic activity against Candida albicans measured by a flow-cytometric assay in cardiovascular-surgery patients.

Authors:  T L Tran; P Auger; A R Marchand; M Carrier; C Pelletier
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

Review 5.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

6.  Emerging Issues in Nosocomial Fungal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

7.  Therapeutic Approach to Candida Sepsis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

8.  Diagnosis of disseminated candidiasis in hospitalized patients using the Cand-Tec latex agglutination assay.

Authors:  M L Sanchez; M A Pfaller; I Cabezudo; M Bale; B Buschelman
Journal:  Mycopathologia       Date:  1992-06       Impact factor: 2.574

9.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

10.  Oral itraconazole in treatment of candidemia in a pediatric intensive care unit.

Authors:  Sunit C Singhi; Thimmapuram C S Reddy; Arunaloke Chakrabarti
Journal:  Indian J Pediatr       Date:  2004-11       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.